Immunogenomics and human disease

Gespeichert in:
Bibliographische Detailangaben
Format: Buch
Sprache:English
Veröffentlicht: Chichester [u.a.] Wiley 2006
Schlagworte:
Online-Zugang:Table of contents only
Publisher description
Klappentext
Inhaltsverzeichnis
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

MARC

LEADER 00000nam a2200000zc 4500
001 BV022945062
003 DE-604
005 20071219
007 t
008 071031s2006 xxkad|| |||| 00||| eng d
010 |a 2005027905 
020 |a 9780470015308  |9 978-0-470-01530-8 
020 |a 0470015306  |c HB : alk. paper  |9 0-470-01530-6 
035 |a (OCoLC)62089790 
035 |a (DE-599)DNB 2005027905 
040 |a DE-604  |b ger  |e aacr 
041 0 |a eng 
044 |a xxk  |c GB 
049 |a DE-355  |a DE-578 
050 0 |a QR184 
082 0 |a 616.07/96 
084 |a WF 9910  |0 (DE-625)148480:  |2 rvk 
084 |a XD 3600  |0 (DE-625)152556:12905  |2 rvk 
084 |a QW 541  |2 nlm 
245 1 0 |a Immunogenomics and human disease  |c [ed. by] András Falus 
264 1 |a Chichester [u.a.]  |b Wiley  |c 2006 
300 |a XXI, 526 p.  |b Ill., graph. Darst. 
336 |b txt  |2 rdacontent 
337 |b n  |2 rdamedia 
338 |b nc  |2 rdacarrier 
650 7 |a Genomica  |2 gtt 
650 7 |a Immuniteit  |2 gtt 
650 7 |a Immunogenetica  |2 gtt 
650 4 |a Immunogénétique 
650 7 |a Methodologie  |2 gtt 
650 4 |a Methode 
650 4 |a Immunogenetics 
650 4 |a Immunogenetics  |x methods 
650 4 |a Genetic Techniques 
650 4 |a Genomics  |x methods 
650 4 |a Immunity  |x genetics 
650 0 7 |a Immungenetik  |0 (DE-588)4130579-6  |2 gnd  |9 rswk-swf 
689 0 0 |a Immungenetik  |0 (DE-588)4130579-6  |D s 
689 0 |C b  |5 DE-604 
700 1 |a Falus, András  |e Sonstige  |4 oth 
856 4 |u http://www.loc.gov/catdir/toc/ecip061/2005027905.html  |3 Table of contents only 
856 4 |u http://www.loc.gov/catdir/enhancements/fy0623/2005027905-d.html  |3 Publisher description 
856 4 2 |m Digitalisierung UB Regensburg  |q application/pdf  |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=016149644&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA  |3 Klappentext 
856 4 2 |m HBZ Datenaustausch  |q application/pdf  |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=016149644&sequence=000004&line_number=0002&func_code=DB_RECORDS&service_type=MEDIA  |3 Inhaltsverzeichnis 
999 |a oai:aleph.bib-bvb.de:BVB01-016149644 

Datensatz im Suchindex

_version_ 1804137184824918016
adam_text One of the major features that distinguishes vertebrates from invertebrates is the presence of a complex immune system. Over millions of years, many novel immune genes and gene families have emerged and their products form sophisticated pathways conferring protection against most pathogens. The Human Genome Project revealed that the ¡mmunoglobulin gene superfamily was one of the largest in the genome, containing more than 2% of all known human genes. High-throughput technologies for the study of DNA, mRNA and proteins, such as microarrays and real-time gene amplification technologies, as well as biobank facilities, are enabling the investigation of these genes and pathways in ever more detail. The parallel development of databases and bioinformatics tools to store and interpret this information will also contribute to greater understanding of the function of the immune system. Genomics is finally changing from an academic discipline to one with real clinical relevance. The study of immune regulation in response to pathogen invasion, to the presence of malignant or allogeneic tissue and, in some cases, to normal autologous tissue requires techniques that study the behaviour of whole systems in parallel. A genome-wide, systems biology approach is needed to understand the genetic and environmental factors that regulate the healthy immune system and its response to pathogens as well as to malignant cells arising within the body. It will also facilitate determining what goes wrong when the immune system attacks normal host cells, as in autoimmune diseases such as Type 1 diabetes. Finally, greater knowledge of the immune system will enable us to use it to promote health and cure disease, through vaccine development - targeting both pathogens and tumour cells - and by manipulation of cellular and humoral defences. This book provides an overview of key conceptual and molecular technologies being deployed in immunogenomics, followed by detailed evaluations of the impact of genomics and systems biology on important areas such as cancer immunology, autoimmunity, allergy and the response to infection. It will be of interest to all those working in immunology, as well as to bioinformaticians and specialists such as oncologists and microbiologists. Contents Preface xiii List of Contributors xvii 1 Genotyping methods and disease gene identification 1 Ramon Kucharzak and Ivo Glynne Gut 1.1 Introduction 1 1.2 Genotyping of single-nucleotide polymorphisms 3 1.3 Methods for interrogating SNPs 4 1.4 Analysis formats 9 1.5 The current generation of methods for SNP genotyping 12 1.6 The next generation 13 1.7 Classical HLA typing 14 1.8 MHC haplotypes 15 1.9 Molecular haplotyping 16 1.10 Microhaplotyping 16 1.11 MHC and disease associations 16 1.12 Conclusions 17 Acknowledgements 17 References 17 2 Glycomics and the sugar code: primer to their structural basis and functionality 23 Hans-Joachim Gabius 2.1 Introduction 23 2.2 Lectins as effectors in functional glycomics 26 2.3 Galectins: structural principles and intrafamily diversity 34 2.4 Ligand-dependent levels of affinity regulation 38 2.5 Perspectives for galectin-dependent medical applications 43 2.6 Conclusions 44 References 44 vi CONTENTS 3 Proteomics in clinical research: perspectives and expectations 53 Ivan Lefkovits, Thomas Grussenmeyer, Peter Matt, Martin Grapow, Michael Lefkovits and Hans-Reinhard Zerkowski 3.1 Introduction 53 3.2 Proteomics: tools and projects 55 3.3 Discussion 62 3.4 Concluding remarks 65 Acknowledgements 65 References 65 4 Chemical genomics: bridging the gap between novel targets and small molecule drug candidates. Contribution to immunology 69 Gyo rgy Dormdn, Takenori Tomohiro, Yasumaru Hatanaka and Ferenc Darvas 4.1 Introduction of chemical genomics: definitions 69 4.2 Chemical microarrays 75 4.3 Small molecule and peptide probes for studying binding interactions through creating a covalent bond 78 4.4 Photochemical proteomics 79 4.5 General aspects of photoaffinity labelling 79 4.6 Photoreactive probes of biomolecules 82 4.7 Application to the immunobiology of living cells 84 4.8 Multifunctional photoprobes for rapid analysis and screening 85 4.9 Advanced application to functional proteomics 88 4.10 Summary 89 References 89 5 Genomic and proteomic analysis of activated human monocytes 95 Ameesha Batheja, George Ho, Xiaoyao Xiao, Xiwei Wang and David Uhlinger 5.1 Primary human monocytes, as a model system 96 5.2 Transcriptional profiling of activated monocytes 97 5.3 Functional genomics 99 5.4 Proteomic analysis of activated human monocytes 102 References 105 6 Bioinformatics as a problem of knowledge representation: applications to some aspects of immunoregulation 107 Sdndor Pongor and Andrds Falus 6.1 Introduction 107 6.2 Sequences and languages 111 6.3 Three-dimensional models 115 6.4 Genomes, proteomes, networks 116 6.5 Computational tools 119 CONTENTS vii 6.6 Information processing in the immune system 120 6.7 Concluding remarks 127 References 129 7 Immune responsiveness of human tumours 133 Ena Wang and Francesco M. Marincola 7.1 Introduction 134 7.2 Defining tumour immune responsiveness 135 7.3 Studying immune responsiveness in human tumours 136 7.4 Immune responsiveness in the context of therapy 138 7.5 The spatial dimension in the quest for the target 139 7.6 Studying the receiving end - tumour as an elusive target for immune recognition 140 7.7 The role of the host in determining immune responsiveness 144 7.8 Concluding remarks 146 References 146 8 Chemokines regulate leukocyte trafficking and organ-specific metastasis 153 Andor Pivarcsi, Anja Mueller and Bernhard Homey 8.1 Chemokines and chemokine receptors 153 8.2 Chemokine receptors in the organ-specific recruitment of tumour cells 157 8.3 Cancer therapy using chemokine receptor inhibitors 162 8.4 Conclusions 163 References 163 9 Towards a unified approach to new target discovery in breast cancer: combining the power of genomics, proteomics and immunology 167 Laszlo G. Radvanyi, Bryan Hennessy, Kurt Gish, Gordon Mills and Neil Berinstein 9.1 Introduction 167 9.2 The use of CGH and DNA microarray-based transcriptional profiling for new target discovery in breast cancer 170 9.3 The challenge of new tumour marker/target validation: traditional techniques meet new proteomics tools 184 9.4 Immunological validation of new target genes in breast cancer: the emerging concept of the cancer immunome 188 9.5 Future prospects: combining target discovery approaches in unified publicly accessible databases 196 References 198 10 Genomics and functional differences of dendritic cell subsets 209 Peter Gogolak and Eva Rajnavolgyi 10.1 Introduction 209 10.2 Origin, differentiation and function of human dendritic cell subsets 210 Vlii CONTENTS 10.3 Tissue localization of dendritic cell subsets 213 10.4 Antigen uptake by dentritic cells 215 10.5 Antigen processing and presentation by dendritic cells 219 10.6 Activation and polarization of dendritic cells 223 10.7 Enhancement of inflammatory responses by NK cells 228 10.8 Suppression of inflammatory responses by natural regulatory T cells 229 10.9 The role of dendritic cells and T-lymphocytes in tumour-specific immune responses 231 References 234 11 Systemic lupus erythematosus: new ideas for diagnosis and treatment 249 Sandeep Krishnan and George C. Tsokos 11.1 Introduction 249 11.2 Strategies for identifying diagnostic markers 250 11.3 Strategies for gene therapy for SLE 258 11.4 Conclusion and future direction 265 References 266 12 Immunogenetics of experimentally induced arthritis 271 Tibor T. Giant and Vyacheslav A. Adarichev 12.1 Rheumatoid arthritis in humans and murine proteoglycan-induced arthritis: introduction 271 12.2 Genetic linkage analysis of PGIA 274 12.3 Transcriptome picture of the disease: gene expression during the initiation and progression of joint inflammation 284 12.4 Conclusions 290 References 291 13 Synovial activation in rheumatoid arthiritis 299 Lars C. Huber, Renate E. Gay and Steffen Gay 13.1 Introduction 299 13.2 Synovial activation in rheumatoid arthritis 301 13.3 Conclusions/perspectives 315 References 316 14 T cell epitope hierarchy in experimental autoimmune models 327 Edit Buzas 14.1 Introduction 327 14.2 Immunodominance and crypticity 328 14.3 Epitope spreading (endogenous self-priming) 328 14.4 Degenerate T cell epitope recognition 329 14.5 The self-reactive TCR repertoire 330 CONTENTS ix 14.6 Thymic antigen presentation 331 14.7 Peripheral antigen presentation 333 14.8 Epitope hierarchy in experimental autoimmune encephalomyelitis 336 14.9 Epitope hierarchy in aggrecan-induced murine arthritis 337 14.10 Summary 343 References 344 15 Gene-gene interaction in immunology as exemplified by studies on autoantibodies against 60 kDa heat-shock protein 351 Zoltdn Prohdszka 15.1 Introduction 352 15.2 Basic features of gene-gene interactions 353 15.3 How to detect epistasis 356 15.4 Autoimmunity to heat-shock proteins 360 15.5 Epistatic effect in the regulation of anti-HSP6 autoantibody levels 362 15.6 Conclusions 363 Appendix 366 References 366 16 Histamine genomics and metabolomics 371 Andrds Falus, Hargita Hegyesi, Susan Darvas, Zoltan Pos and Peter Igaz 16.1 Introduction 371 16.2 Chemistry 372 16.3 Biosynthesis and biotransformation 372 16.4 Histidine decarboxylase - gene and protein 374 16.5 Catabolic pathways of histamine 380 16.6 Histamine receptors 381 16.7 Histamine and cytokines, relation to the T cell polarization of the immune response 387 16.8 Histamine and tumour growth 389 16.9 Histamine research: an insight into metabolomics, lessons from HDC-deficient mice 389 16.10 Histamine genomics on databases 390 References 390 17 The histamine H4 receptor: drug discovery in the post-genomic era 395 Mall O Donnell, Paul J. Dunford and Robin L Thurmond 17.1 Introduction 395 17.2 Cloning of H3R and H4R 396 17.3 Generation of H^R-specific antagonists 398 17.4 High-throughput screening 399 17.5 Functional studies 400 17.6 Future prospects 404 References 405 x CONTENTS 18 Application of microarray technology to bronchial asthma 407 Kenji Izuhara, Kazuhiko Arima, Sachiko Kanaji, Kiyonari Masumoto and Taisuke Kanaji 18.1 Introduction 407 18.2 Lung tissue as source 410 18.3 Particular cell as source 411 18.4 Conclusions 414 Acknowledgements 415 References 415 19 Genomic investigation of asthma in human and animal models 419 Csaba Szalai 19.1 Introduction 419 19.2 Methods for localization of asthma susceptibility genes 421 19.3 Results of the association studies and genome-wide screens in humans 422 19.4 Animal models of asthma 434 19.5 Concluding remarks 438 References 438 20 Primary immunodeficiencies: genotype-phenotype correlations 443 Mauno Vihinen and Anne Durandy 20.1 Introduction 443 20.2 Immunodeficiency data services 445 20.3 Genotype-phenotype correlations 447 20.4 ADA deficiency 447 20.5 RAG1 and RAG2 deficiency 450 20.6 AID deficiency 451 20.7 WAS 452 20.8 XL A 454 20.9 Why GP correlations are not more common 456 References 457 21 Transcriptional profiling of dentritic cells in response to pathogens 461 Maria Foti, Francesco Granucci, Mattia Pelizzola, Norman Pavelka, Ottavio Beretta, Caterina Vizzardelli, Matteo Urbano, Ivan Zanoni, Giusy Capuano, Francesco Mingozzi and Paola Ricciardi-Castagnoli 21.1 Transcriptional profiling to study the complexity of the immune system 462 21.2 DC subsets and functional studies 463 21.3 DC at the intersection between innate and adaptive immunity 469 21.4 DC and infectious diseases 472 21.5 DC and bacteria interaction 472 21.6 DC and virus interaction 474 CONTENTS xi 21.7 DC and parasite interaction 475 21.8 Leishmania mexicana molecular signature 478 21.9 Conclusions 478 References 480 22 Parallel biology: a systematic approach to drug target and biomarker discovery in chronic obstructive pulmonary disease 487 Laszlo Takacs 22.1 Introduction 487 22.2 Genome research is a specific application of parallel biology often regarded as systems biology 489 22.3 Chronic obstructive pulmonary disease 489 22.4 Goals of the study 491 22.5 Methods 491 22.6 Results 494 Appendix 495 References 495 23 Mycobacterial granulomas: a genomic approach 497 Laura H. Hogan, Dominic O. Co and Matyas Sandor 23.1 Introduction 497 23.2 Initial infection of macrophage 499 23.3 Mycobacterial gene expression in the host 502 23.4 Host genes important to granuloma formation 508 23.5 Granulomatous inflammation as an ecological system 509 References 510 Index 515
adam_txt One of the major features that distinguishes vertebrates from invertebrates is the presence of a complex immune system. Over millions of years, many novel immune genes and gene families have emerged and their products form sophisticated pathways conferring protection against most pathogens. The Human Genome Project revealed that the ¡mmunoglobulin gene superfamily was one of the largest in the genome, containing more than 2% of all known human genes. High-throughput technologies for the study of DNA, mRNA and proteins, such as microarrays and real-time gene amplification technologies, as well as biobank facilities, are enabling the investigation of these genes and pathways in ever more detail. The parallel development of databases and bioinformatics tools to store and interpret this information will also contribute to greater understanding of the function of the immune system. Genomics is finally changing from an academic discipline to one with real clinical relevance. The study of immune regulation in response to pathogen invasion, to the presence of malignant or allogeneic tissue and, in some cases, to normal autologous tissue requires techniques that study the behaviour of whole systems in parallel. A genome-wide, systems biology approach is needed to understand the genetic and environmental factors that regulate the healthy immune system and its response to pathogens as well as to malignant cells arising within the body. It will also facilitate determining what goes wrong when the immune system attacks normal host cells, as in autoimmune diseases such as Type 1 diabetes. Finally, greater knowledge of the immune system will enable us to use it to promote health and cure disease, through vaccine development - targeting both pathogens and tumour cells - and by manipulation of cellular and humoral defences. This book provides an overview of key conceptual and molecular technologies being deployed in immunogenomics, followed by detailed evaluations of the impact of genomics and systems biology on important areas such as cancer immunology, autoimmunity, allergy and the response to infection. It will be of interest to all those working in immunology, as well as to bioinformaticians and specialists such as oncologists and microbiologists. Contents Preface xiii List of Contributors xvii 1 Genotyping methods and disease gene identification 1 Ramon Kucharzak and Ivo Glynne Gut 1.1 Introduction 1 1.2 Genotyping of single-nucleotide polymorphisms 3 1.3 Methods for interrogating SNPs 4 1.4 Analysis formats 9 1.5 The current generation of methods for SNP genotyping 12 1.6 The next generation 13 1.7 Classical HLA typing 14 1.8 MHC haplotypes 15 1.9 Molecular haplotyping 16 1.10 Microhaplotyping 16 1.11 MHC and disease associations 16 1.12 Conclusions 17 Acknowledgements 17 References 17 2 Glycomics and the sugar code: primer to their structural basis and functionality 23 Hans-Joachim Gabius 2.1 Introduction 23 2.2 Lectins as effectors in functional glycomics 26 2.3 Galectins: structural principles and intrafamily diversity 34 2.4 Ligand-dependent levels of affinity regulation 38 2.5 Perspectives for galectin-dependent medical applications 43 2.6 Conclusions 44 References 44 vi CONTENTS 3 Proteomics in clinical research: perspectives and expectations 53 Ivan Lefkovits, Thomas Grussenmeyer, Peter Matt, Martin Grapow, Michael Lefkovits and Hans-Reinhard Zerkowski 3.1 Introduction 53 3.2 Proteomics: tools and projects 55 3.3 Discussion 62 3.4 Concluding remarks 65 Acknowledgements 65 References 65 4 Chemical genomics: bridging the gap between novel targets and small molecule drug candidates. Contribution to immunology 69 Gyo'rgy Dormdn, Takenori Tomohiro, Yasumaru Hatanaka and Ferenc Darvas 4.1 Introduction of chemical genomics: definitions 69 4.2 Chemical microarrays 75 4.3 Small molecule and peptide probes for studying binding interactions through creating a covalent bond 78 4.4 Photochemical proteomics 79 4.5 General aspects of photoaffinity labelling 79 4.6 Photoreactive probes of biomolecules 82 4.7 Application to the immunobiology of living cells 84 4.8 Multifunctional photoprobes for rapid analysis and screening 85 4.9 Advanced application to functional proteomics 88 4.10 Summary 89 References 89 5 Genomic and proteomic analysis of activated human monocytes 95 Ameesha Batheja, George Ho, Xiaoyao Xiao, Xiwei Wang and David Uhlinger 5.1 Primary human monocytes, as a model system 96 5.2 Transcriptional profiling of activated monocytes 97 5.3 Functional genomics 99 5.4 Proteomic analysis of activated human monocytes 102 References 105 6 Bioinformatics as a problem of knowledge representation: applications to some aspects of immunoregulation 107 Sdndor Pongor and Andrds Falus 6.1 Introduction 107 6.2 Sequences and languages 111 6.3 Three-dimensional models 115 6.4 Genomes, proteomes, networks 116 6.5 Computational tools 119 CONTENTS vii 6.6 Information processing in the immune system 120 6.7 Concluding remarks 127 References 129 7 Immune responsiveness of human tumours 133 Ena Wang and Francesco M. Marincola 7.1 Introduction 134 7.2 Defining tumour immune responsiveness 135 7.3 Studying immune responsiveness in human tumours 136 7.4 Immune responsiveness in the context of therapy 138 7.5 The spatial dimension in the quest for the target 139 7.6 Studying the receiving end - tumour as an elusive target for immune recognition 140 7.7 The role of the host in determining immune responsiveness 144 7.8 Concluding remarks 146 References 146 8 Chemokines regulate leukocyte trafficking and organ-specific metastasis 153 Andor Pivarcsi, Anja Mueller and Bernhard Homey 8.1 Chemokines and chemokine receptors 153 8.2 Chemokine receptors in the organ-specific recruitment of tumour cells 157 8.3 Cancer therapy using chemokine receptor inhibitors 162 8.4 Conclusions 163 References 163 9 Towards a unified approach to new target discovery in breast cancer: combining the power of genomics, proteomics and immunology 167 Laszlo G. Radvanyi, Bryan Hennessy, Kurt Gish, Gordon Mills and Neil Berinstein 9.1 Introduction 167 9.2 The use of CGH and DNA microarray-based transcriptional profiling for new target discovery in breast cancer 170 9.3 The challenge of new tumour marker/target validation: traditional techniques meet new proteomics tools 184 9.4 Immunological validation of new target genes in breast cancer: the emerging concept of the cancer 'immunome' 188 9.5 Future prospects: combining target discovery approaches in unified publicly accessible databases 196 References 198 10 Genomics and functional differences of dendritic cell subsets 209 Peter Gogolak and Eva Rajnavolgyi 10.1 Introduction 209 10.2 Origin, differentiation and function of human dendritic cell subsets 210 Vlii CONTENTS 10.3 Tissue localization of dendritic cell subsets 213 10.4 Antigen uptake by dentritic cells 215 10.5 Antigen processing and presentation by dendritic cells 219 10.6 Activation and polarization of dendritic cells 223 10.7 Enhancement of inflammatory responses by NK cells 228 10.8 Suppression of inflammatory responses by natural regulatory T cells 229 10.9 The role of dendritic cells and T-lymphocytes in tumour-specific immune responses 231 References 234 11 Systemic lupus erythematosus: new ideas for diagnosis and treatment 249 Sandeep Krishnan and George C. Tsokos 11.1 Introduction 249 11.2 Strategies for identifying diagnostic markers 250 11.3 Strategies for gene therapy for SLE 258 11.4 Conclusion and future direction 265 References 266 12 Immunogenetics of experimentally induced arthritis 271 Tibor T. Giant and Vyacheslav A. Adarichev 12.1 Rheumatoid arthritis in humans and murine proteoglycan-induced arthritis: introduction 271 12.2 Genetic linkage analysis of PGIA 274 12.3 Transcriptome picture of the disease: gene expression during the initiation and progression of joint inflammation 284 12.4 Conclusions 290 References 291 13 Synovial activation in rheumatoid arthiritis 299 Lars C. Huber, Renate E. Gay and Steffen Gay 13.1 Introduction 299 13.2 Synovial activation in rheumatoid arthritis 301 13.3 Conclusions/perspectives 315 References 316 14 T cell epitope hierarchy in experimental autoimmune models 327 Edit Buzas 14.1 Introduction 327 14.2 Immunodominance and crypticity 328 14.3 Epitope spreading (endogenous self-priming) 328 14.4 Degenerate T cell epitope recognition 329 14.5 The self-reactive TCR repertoire 330 CONTENTS ix 14.6 Thymic antigen presentation 331 14.7 Peripheral antigen presentation 333 14.8 Epitope hierarchy in experimental autoimmune encephalomyelitis 336 14.9 Epitope hierarchy in aggrecan-induced murine arthritis 337 14.10 Summary 343 References 344 15 Gene-gene interaction in immunology as exemplified by studies on autoantibodies against 60 kDa heat-shock protein 351 Zoltdn Prohdszka 15.1 Introduction 352 15.2 Basic features of gene-gene interactions 353 15.3 How to detect epistasis 356 15.4 Autoimmunity to heat-shock proteins 360 15.5 Epistatic effect in the regulation of anti-HSP6 autoantibody levels 362 15.6 Conclusions 363 Appendix 366 References 366 16 Histamine genomics and metabolomics 371 Andrds Falus, Hargita Hegyesi, Susan Darvas, Zoltan Pos and Peter Igaz 16.1 Introduction 371 16.2 Chemistry 372 16.3 Biosynthesis and biotransformation 372 16.4 Histidine decarboxylase - gene and protein 374 16.5 Catabolic pathways of histamine 380 16.6 Histamine receptors 381 16.7 Histamine and cytokines, relation to the T cell polarization of the immune response 387 16.8 Histamine and tumour growth 389 16.9 Histamine research: an insight into metabolomics, lessons from HDC-deficient mice 389 16.10 Histamine genomics on databases 390 References 390 17 The histamine H4 receptor: drug discovery in the post-genomic era 395 Mall O'Donnell, Paul J. Dunford and Robin L Thurmond 17.1 Introduction 395 17.2 Cloning of H3R and H4R 396 17.3 Generation of H^R-specific antagonists 398 17.4 High-throughput screening 399 17.5 Functional studies 400 17.6 Future prospects 404 References 405 x CONTENTS 18 Application of microarray technology to bronchial asthma 407 Kenji Izuhara, Kazuhiko Arima, Sachiko Kanaji, Kiyonari Masumoto and Taisuke Kanaji 18.1 Introduction 407 18.2 Lung tissue as 'source' 410 18.3 Particular cell as'source' 411 18.4 Conclusions 414 Acknowledgements 415 References 415 19 Genomic investigation of asthma in human and animal models 419 Csaba Szalai 19.1 Introduction 419 19.2 Methods for localization of asthma susceptibility genes 421 19.3 Results of the association studies and genome-wide screens in humans 422 19.4 Animal models of asthma 434 19.5 Concluding remarks 438 References 438 20 Primary immunodeficiencies: genotype-phenotype correlations 443 Mauno Vihinen and Anne Durandy 20.1 Introduction 443 20.2 Immunodeficiency data services 445 20.3 Genotype-phenotype correlations 447 20.4 ADA deficiency 447 20.5 RAG1 and RAG2 deficiency 450 20.6 AID deficiency 451 20.7 WAS 452 20.8 XL A 454 20.9 Why GP correlations are not more common 456 References 457 21 Transcriptional profiling of dentritic cells in response to pathogens 461 Maria Foti, Francesco Granucci, Mattia Pelizzola, Norman Pavelka, Ottavio Beretta, Caterina Vizzardelli, Matteo Urbano, Ivan Zanoni, Giusy Capuano, Francesco Mingozzi and Paola Ricciardi-Castagnoli 21.1 Transcriptional profiling to study the complexity of the immune system 462 21.2 DC subsets and functional studies 463 21.3 DC at the intersection between innate and adaptive immunity 469 21.4 DC and infectious diseases 472 21.5 DC and bacteria interaction 472 21.6 DC and virus interaction 474 CONTENTS xi 21.7 DC and parasite interaction 475 21.8 Leishmania mexicana molecular signature 478 21.9 Conclusions 478 References 480 22 Parallel biology: a systematic approach to drug target and biomarker discovery in chronic obstructive pulmonary disease 487 Laszlo Takacs 22.1 Introduction 487 22.2 Genome research is a specific application of parallel biology often regarded as systems biology 489 22.3 Chronic obstructive pulmonary disease 489 22.4 Goals of the study 491 22.5 Methods 491 22.6 Results 494 Appendix 495 References 495 23 Mycobacterial granulomas: a genomic approach 497 Laura H. Hogan, Dominic O. Co and Matyas Sandor 23.1 Introduction 497 23.2 Initial infection of macrophage 499 23.3 Mycobacterial gene expression in the host 502 23.4 Host genes important to granuloma formation 508 23.5 Granulomatous inflammation as an ecological system 509 References 510 Index 515
any_adam_object 1
any_adam_object_boolean 1
building Verbundindex
bvnumber BV022945062
callnumber-first Q - Science
callnumber-label QR184
callnumber-raw QR184
callnumber-search QR184
callnumber-sort QR 3184
callnumber-subject QR - Microbiology
classification_rvk WF 9910
XD 3600
ctrlnum (OCoLC)62089790
(DE-599)DNB 2005027905
dewey-full 616.07/96
dewey-hundreds 600 - Technology (Applied sciences)
dewey-ones 616 - Diseases
dewey-raw 616.07/96
dewey-search 616.07/96
dewey-sort 3616.07 296
dewey-tens 610 - Medicine and health
discipline Biologie
Medizin
discipline_str_mv Biologie
Medizin
format Book
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02208nam a2200565zc 4500</leader><controlfield tag="001">BV022945062</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20071219 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">071031s2006 xxkad|| |||| 00||| eng d</controlfield><datafield tag="010" ind1=" " ind2=" "><subfield code="a">2005027905</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780470015308</subfield><subfield code="9">978-0-470-01530-8</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0470015306</subfield><subfield code="c">HB : alk. paper</subfield><subfield code="9">0-470-01530-6</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)62089790</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DNB 2005027905</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">xxk</subfield><subfield code="c">GB</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield><subfield code="a">DE-578</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">QR184</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.07/96</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">WF 9910</subfield><subfield code="0">(DE-625)148480:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XD 3600</subfield><subfield code="0">(DE-625)152556:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">QW 541</subfield><subfield code="2">nlm</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Immunogenomics and human disease</subfield><subfield code="c">[ed. by] András Falus</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Chichester [u.a.]</subfield><subfield code="b">Wiley</subfield><subfield code="c">2006</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XXI, 526 p.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Genomica</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Immuniteit</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Immunogenetica</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Immunogénétique</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Methodologie</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Methode</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Immunogenetics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Immunogenetics</subfield><subfield code="x">methods</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Genetic Techniques</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Genomics</subfield><subfield code="x">methods</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Immunity</subfield><subfield code="x">genetics</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Immungenetik</subfield><subfield code="0">(DE-588)4130579-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Immungenetik</subfield><subfield code="0">(DE-588)4130579-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="C">b</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Falus, András</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2=" "><subfield code="u">http://www.loc.gov/catdir/toc/ecip061/2005027905.html</subfield><subfield code="3">Table of contents only</subfield></datafield><datafield tag="856" ind1="4" ind2=" "><subfield code="u">http://www.loc.gov/catdir/enhancements/fy0623/2005027905-d.html</subfield><subfield code="3">Publisher description</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">Digitalisierung UB Regensburg</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&amp;doc_library=BVB01&amp;local_base=BVB01&amp;doc_number=016149644&amp;sequence=000002&amp;line_number=0001&amp;func_code=DB_RECORDS&amp;service_type=MEDIA</subfield><subfield code="3">Klappentext</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">HBZ Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&amp;doc_library=BVB01&amp;local_base=BVB01&amp;doc_number=016149644&amp;sequence=000004&amp;line_number=0002&amp;func_code=DB_RECORDS&amp;service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-016149644</subfield></datafield></record></collection>
id DE-604.BV022945062
illustrated Illustrated
index_date 2024-07-02T18:59:27Z
indexdate 2024-07-09T21:08:16Z
institution BVB
isbn 9780470015308
0470015306
language English
lccn 2005027905
oai_aleph_id oai:aleph.bib-bvb.de:BVB01-016149644
oclc_num 62089790
open_access_boolean
owner DE-355
DE-BY-UBR
DE-578
owner_facet DE-355
DE-BY-UBR
DE-578
physical XXI, 526 p. Ill., graph. Darst.
publishDate 2006
publishDateSearch 2006
publishDateSort 2006
publisher Wiley
record_format marc
spelling Immunogenomics and human disease [ed. by] András Falus
Chichester [u.a.] Wiley 2006
XXI, 526 p. Ill., graph. Darst.
txt rdacontent
n rdamedia
nc rdacarrier
Genomica gtt
Immuniteit gtt
Immunogenetica gtt
Immunogénétique
Methodologie gtt
Methode
Immunogenetics
Immunogenetics methods
Genetic Techniques
Genomics methods
Immunity genetics
Immungenetik (DE-588)4130579-6 gnd rswk-swf
Immungenetik (DE-588)4130579-6 s
b DE-604
Falus, András Sonstige oth
http://www.loc.gov/catdir/toc/ecip061/2005027905.html Table of contents only
http://www.loc.gov/catdir/enhancements/fy0623/2005027905-d.html Publisher description
Digitalisierung UB Regensburg application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=016149644&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Klappentext
HBZ Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=016149644&sequence=000004&line_number=0002&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis
spellingShingle Immunogenomics and human disease
Genomica gtt
Immuniteit gtt
Immunogenetica gtt
Immunogénétique
Methodologie gtt
Methode
Immunogenetics
Immunogenetics methods
Genetic Techniques
Genomics methods
Immunity genetics
Immungenetik (DE-588)4130579-6 gnd
subject_GND (DE-588)4130579-6
title Immunogenomics and human disease
title_auth Immunogenomics and human disease
title_exact_search Immunogenomics and human disease
title_exact_search_txtP Immunogenomics and human disease
title_full Immunogenomics and human disease [ed. by] András Falus
title_fullStr Immunogenomics and human disease [ed. by] András Falus
title_full_unstemmed Immunogenomics and human disease [ed. by] András Falus
title_short Immunogenomics and human disease
title_sort immunogenomics and human disease
topic Genomica gtt
Immuniteit gtt
Immunogenetica gtt
Immunogénétique
Methodologie gtt
Methode
Immunogenetics
Immunogenetics methods
Genetic Techniques
Genomics methods
Immunity genetics
Immungenetik (DE-588)4130579-6 gnd
topic_facet Genomica
Immuniteit
Immunogenetica
Immunogénétique
Methodologie
Methode
Immunogenetics
Immunogenetics methods
Genetic Techniques
Genomics methods
Immunity genetics
Immungenetik
url http://www.loc.gov/catdir/toc/ecip061/2005027905.html
http://www.loc.gov/catdir/enhancements/fy0623/2005027905-d.html
http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=016149644&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA
http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=016149644&sequence=000004&line_number=0002&func_code=DB_RECORDS&service_type=MEDIA
work_keys_str_mv AT falusandras immunogenomicsandhumandisease